N(G)-Nitroarginine-4-nitroanilide

TargetMol
Product Code: TAR-T25843
Supplier: TargetMol
CodeSizePrice
TAR-T25843-100mg100mg£250.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
N(G)-Nitroarginine-4-nitroanilide is an anti-nociceptive in mice.
CAS:
85697-89-8
Formula:
C12H17N7O5
Molecular Weight:
339.312
Purity:
0.98
SMILES:
N[C@@H](CCCNC(=N)N[N+]([O-])=O)C(=O)Nc1ccc(cc1)[N+]([O-])=O

References

1. Babbedge RC, Wallace P, Gaffen ZA, Hart SL, Moore PK. L-NG-nitro arginine p-nitroanilide (L-NAPNA) is anti-nociceptive in the mouse. Neuroreport. 1993 Mar;4(3):307-10. PubMed PMID: 7682856. 2. Rivot JP, Barraud J, Mont?cot C, Jost B, Besson JM. Nitric oxide (NO): in vivo electrochemical monitoring in the dorsal horn of the spinal cord of the rat. Brain Res. 1997 Oct 31;773(1-2):66-75. PubMed PMID: 9409706. 3. Vroom MB, Pfaffendorf M, van Wezel HB, van Zwieten PA. Effect of phosphodiesterase inhibitors on human arteries in vitro. Br J Anaesth. 1996 Jan;76(1):122-9. PubMed PMID: 8672353. 4. Rice AS. Topical spinal administration of a nitric oxide synthase inhibitor prevents the hyper-reflexia associated with a rat model of persistent visceral pain. Neurosci Lett. 1995 Mar 3;187(2):111-4. PubMed PMID: 7540269.